GSK Lotronex Plan Follows Accutane Model; Relaunch “Months” Away

GlaxoSmithKline's Lotronex risk management program will follow the Accutane model

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet